Aera Therapeutics
About:
Aera Therapeutics is a biotechnology firm that employs its own protein nanoparticle (PNP) delivery platform.
Website: https://aeratx.com
Twitter/X: AeraTx
Top Investors: Google Ventures, Lux Capital, ARCH Venture Partners
Description:
Aera Therapeutics is a biotechnology company that uses its proprietary protein nanoparticle (PNP) delivery platform to help genetic medicines reach their full potential. Aera's platform, which is based on endogenous human proteins, is being developed to address the limitations of current delivery technologies and to extend the reach of genetic medicines to different tissues and applications, thereby benefiting more patients across a broader range of disease areas. In addition, Aera's licensed technology includes a therapeutic enzyme platform based on the discovery of novel, compact, and programmable gene-editing enzymes.
$193M
Boston, Massachusetts, United States
2021-01-01
katie(AT)1abmedia.com
Feng Zhang, Jason Shepherd
101-250
2023-02-16
Private
© 2025 bioDAO.ai